SCHEMBL17824314

SCHEMBL17824314

Cc1cc(NC(=O)Cn2c(NCc3ccccc3)nc3ccccc32)no1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.68
ALDH1A1 P00352 2/20 0.57
HTT P42858 2/20 0.57
HPGD P15428 1/20 0.57
SAE1 Q9UBE0 1/20 0.57
UBA2 Q9UBT2 1/20 0.57
LMNA P02545 4/20 0.53
TSHR P16473 1/20 0.53
PKM P14618 2/20 0.50
GAA P10253 2/20 0.50
USP2 O75604 1/20 0.50
MEN1 O00255 1/20 0.50
RAB9A P51151 1/20 0.50
KMT2A Q03164 1/20 0.50
EGFR P00533 1/20 0.49
MAPK1 P28482 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
KDM4E B2RXH2 1/20 0.48
HSD17B10 Q99714 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19714549 0.85 LMNA (0.52) L3MBTL1ALDH1A1HTTLMNATSHR
SCHEMBL17824308 0.84 LMNA (0.53) L3MBTL1ALDH1A1HTTLMNATSHR
SCHEMBL17824303 0.84 LMNA (0.53) L3MBTL1ALDH1A1HTTLMNATSHR
SCHEMBL17824295 0.83 MEN1 (0.52) L3MBTL1ALDH1A1HTTLMNATSHR
SCHEMBL17824286 0.83 LMNA (0.52) L3MBTL1ALDH1A1HTTLMNATSHR
SCHEMBL19714456 0.82 MEN1 (0.54) ALDH1A1HTTLMNATSHRPKM
SCHEMBL17833377 0.81 L3MBTL1 (0.64) L3MBTL1ALDH1A1HTTHPGDSAE1
SCHEMBL19714466 0.81 KMT2A (0.65) HTTLMNATSHRPKMUSP2
SCHEMBL19714478 0.81 LMNA (0.74) ALDH1A1HTTLMNATSHRPKM
SCHEMBL17824304 0.80 LMNA (0.51) ALDH1A1HTTLMNATSHRPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200377505-A1 BENZIMIDAZOLES AND AZA-BENZIMIDAZOLES, AND METHODS OF USE THEREOF GFB (ABC), LLC 2020-12-03 US disclosed
WO-2019028308-A1 BENZIMIDAZOLES AND AZA-BENZIMIDAZOLES, AND METHODS OF USE THEREOF GOLDFINCH BIO, INC. (US) 2019-02-07 WO disclosed
US-20170362184-A1 PRO-SURVIVAL COMPOUNDS HERIOT-WATT UNIVERSITY (GB) 2017-12-21 US disclosed
US-20170362184-A1 PRO-SURVIVAL COMPOUNDS HERIOT-WATT UNIVERSITY (GB) 2017-12-21 US disclosed
US-20170362184-A1 PRO-SURVIVAL COMPOUNDS HERIOT-WATT UNIVERSITY (GB) 2017-12-21 US disclosed
EP-3230275-A1 PRO-SURVIVAL COMPOUNDS University Court of The University of Glasgow (GB) 2017-10-18 EP disclosed
WO-2016092327-A1 PRO-SURVIVAL COMPOUNDS UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) 2016-06-16 WO disclosed
WO-2016092327-A1 PRO-SURVIVAL COMPOUNDS UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) 2016-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377505-A1 BENZIMIDAZOLES AND AZA-BENZIMIDAZOLES, AND METHODS OF USE THEREOF AZI2, ATP6V1B1, GLS L3MBTL1 4462/4885ALDH1A1 54/4885HTT 3957/4885
US-20170362184-A1 PRO-SURVIVAL COMPOUNDS MCL1, MKI67, MORF4L1 L3MBTL1 66/4885ALDH1A1 95/4885HTT 3064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.